About Vivobio Discovery Services Private Limited
Data last updated: 08 February 2026
Vivobio Discovery Services Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Vivo Bio Tech Limited. It specialises in preventive healthcare, a part of the broader healthcare sector. Incorporated on 23 October 2009, the company has been in operation for over 17 years.
Registered with ROC Hyderabad under CIN U24232TG2009PTC065604.
Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shyam Sunder Tipparaju and Kalyan Ram Mangipudi.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 8 – 2 – 672/5&6 3Rd Floor Ilyas Mohammed Khan Estate Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2023, the company reported a revenue of ₹14.89 Lakh.
It operates as a subsidiary of Vivo Bio Tech Limited.
The company is associated with 1 brand - Vivo Bio Tech.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vivobio.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address8 – 2 – 672/5&6 3Rd Floor Ilyas Mohammed Khan Estate Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034
-
IndustryHealthcare, Preventive Health Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vivobio Discovery Services Private Limited
Vivobio Discovery Services Private Limited has one previous CIN (Corporate Identification Number): U24232AP2009PTC065604. The current CIN is U24232TG2009PTC065604, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2009PTC065604 | Current |
| U24232AP2009PTC065604 | Previous |
Associated Brands with Vivobio Discovery Services Private Limited
Vivobio Discovery Services Private Limited operates one associated brand: Vivo Bio Tech. These brands represent Vivobio Discovery Services Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| CRO providing drug development, discovery and biologic research services | vivobio.com |
Competitors & Alternatives of Vivobio Discovery Services Private Limited
Brands and companies operating in the same space as Vivobio Discovery Services Private Limited include GenOway, PsychoGenics, PharmaLegacy Laboratories and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
GenOway
|
Provider of transgenic rodent models and customized cell lines for preclinical development | Lyon, France, France | 1999 |
PsychoGenics
|
Preclinical CRO services for CNS and orphan disorders are offered. | Tarrytown, United States, United States | 1999 |
PharmaLegacy Laboratories
|
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas | Shanghai, China, China | 2008 |
TransCure bioServices
|
Humanized mouse models are developed for preclinical immune drug studies. | Archamps, France, France | 2012 |
InVivo Biosystems
|
Animal models are supplied for in-vivo analytical services. | United States | 2019 |
Explora BioLabs
|
Discovery pharmacology and vivarium services are provided to biotech clients. | San Diego, United States, United States | 2004 |
Noble Life Sciences
|
Preclinical contract research organization offering standard GLP and non-GLP services | Woodbine, United States, United States | 2010 |
ZeClinics
|
Zebrafish models for toxicity studies are developed by ZeClinics CRO. | Barcelona, Spain, Spain | 2013 |
Zebrafish Lab
|
Zebrafish assays are utilized for preclinical and environmental evaluations. | Noain, Spain, Spain | 2015 |
Business Activity of Vivobio Discovery Services Private Limited
Vivobio Discovery Services Private Limited operates primarily in the professional, scientific and technical sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Professional, Scientific and Technical | ********* | Other professional, scientific and technical activities | ********* |
Auditor Details of Vivobio Discovery Services Private Limited
Vivobio Discovery Services Private Limited is audited by P Murali&Co for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P Murali&Co | blur-value | blur-value | blur-value |
Board of Directors of Vivobio Discovery Services Private Limited
Vivobio Discovery Services Private Limited is currently managed by 3 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Shyam Sunder Tipparaju
Also directs:
Vivo Bio Tech Limited, Vivobio Discovery Services Private Limited, Vivobio Labs Private Limited and 5 more
|
Director | 05 Feb 2024 | 2 Years 5 Months | Current |
|
Kalyan Ram Mangipudi
Also directs:
Vivo Bio Tech Limited, Vivobio Discovery Services Private Limited, Bharat Megawatts Gen Private Limited and 5 more
|
Director | 31 Mar 2018 | 8 Years 3 Months | Current |
|
Sankaranarayanan Alangudi
Also directs:
Vivo Bio Tech Limited, Vivobio Discovery Services Private Limited, Vivobio Labs Private Limited and 3 more
|
Director | 23 Oct 2009 | 16 Years 8 Months | Current |
Financials of Vivobio Discovery Services Private Limited FY 2025 filings available
Vivobio Discovery Services Private Limited reported revenue of ₹14.89 Lakh (up ) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Vivobio Discovery Services Private Limited
As of FY 2023, Vivobio Discovery Services Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Vivobio Discovery Services Private Limited
Vivobio Discovery Services Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Vivobio Discovery Services Private Limited
View historical data on people associated with Vivobio Discovery Services Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Vivobio Discovery Services Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vivobio Discovery Services Private Limited
GSTIN & GST Filing Data of Vivobio Discovery Services Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vivobio Discovery Services Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vivobio Discovery Services Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vivobio Discovery Services Private Limited
MSME Payment Delays by Vivobio Discovery Services Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vivobio Discovery Services Private Limited
Subsidiaries & Group Companies of Vivobio Discovery Services Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vivobio Discovery Services Private Limited with ownership details.
MCA Filings & Documents of Vivobio Discovery Services Private Limited
MCA Filings & Documents of Vivobio Discovery Services Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vivobio Discovery Services Private Limited
Recent News on Vivobio Discovery Services Private Limited
Frequently Asked Questions about Vivobio Discovery Services Private Limited
Vivobio Discovery Services Private Limited is an active private limited company in the healthcare sector based in Hyderabad, Telangana, India. It was incorporated on 23 October 2009 (17+ years old) and is registered under CIN U24232TG2009PTC065604.
Vivobio Discovery Services Private Limited reported revenue of ₹14.89 Lakh for FY 2023.
The current directors of Vivobio Discovery Services Private Limited are:
The primary industry of Vivobio Discovery Services Private Limited is healthcare. The company specifically operates in preventive health services. The company is currently active in this sector.
Vivobio Discovery Services Private Limited can be reached at the registered office: 8 – 2 – 6725&6 3Rd Floor Ilyas Mohammed Khan Estate Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034, or through the website vivobio.com.
The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.